Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anderson See Gaweco is active.

Publication


Featured researches published by Anderson See Gaweco.


Journal of Investigative Dermatology | 2009

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis

M. Boy; Cunshan Wang; Bethanie Wilkinson; Vincent Chow; Alan T. Clucas; James G. Krueger; Anderson See Gaweco; Samuel H. Zwillich; Paul S. Changelian; Gary Chan

CONFLICT OF INTEREST The authors state no conflict of interest. Penkanok Sriwiriyanont, Akira Hachiya, William L. Pickens, Shigeru Moriwaki, Atsushi Ohuchi, Takashi Kitahara, Yoshinori Takema, William J. Kitzmiller, Marty O. Visscher, Alexander Bello, Ryoji Tsuboi and Gary P. Kobinger Skin Sciences Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA; Kao Biological Science Laboratories, Haga, Tochigi, Japan; Department of Dermatology, Tokyo Medical University, Tokyo, Japan; Department of Surgery, University of Cincinnati, Cincinnati, OH, USA; Special Pathogens Program, Department of Medical Microbiology, National Microbiology Laboratory, Public Health Agency of Canada, University of Manitoba, Winnipeg, Canada E-mail: [email protected]


Science | 2003

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

Paul S. Changelian; Mark Edward Flanagan; Douglas J. Ball; Craig R. Kent; Kelly S. Magnuson; William H. Martin; Bonnie J. Rizzuti; Perry S. Sawyer; Bret D. Perry; Sandra P. McCurdy; Elizabeth M. Kudlacz; Maryrose J. Conklyn; Eileen A. Elliott; Erika R. Koslov; Michael B. Fisher; Timothy J. Strelevitz; Kwansik Yoon; David A. Whipple; Jianmin Sun; Michael John Munchhof; John L. Doty; Jeffrey M. Casavant; Todd Andrew Blumenkopf; Michael Hines; Matthew Frank Brown; Brett M. Lillie; Chakrapani Subramanyam; Chang Shang-Poa; Anthony J. Milici; Gretchen E Beckius


Archive | 2004

Stent with therapeutically active drug coated thereon

Paul S. Changelian; Anderson See Gaweco


Archive | 2003

Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents

Matthew Frank Brown; Anderson See Gaweco; Ronald P. Gladue; John Charles Kath; Christopher Stanley Poss


Archive | 2003

Use of piperazine derivatives as ccr1 antagonists

Laura Cook Blumberg; Matthew Frank Brown; Anderson See Gaweco; Ronald P. Gladue; Matthew Merrill Hayward; Gregory Dean Lundquist; Christopher Stanley Poss; Andre Shavnya


Archive | 2003

Methods of using CCR1 antagonists as immunomodulatory agents

Matthew Frank Brown; Anderson See Gaweco; Ronald P. Gladue; John Charles Kath; Christopher Stanley Poss


Archive | 2003

Methods of using piperazine derivatives

Laura Cook Blumberg; Matthew Frank Brown; Anderson See Gaweco; Ronald P. Gladue; Matthew Merrill Hayward; Gregory Dean Lundquist; Christopher Stanley Poss; Andrei Shavnya


Archive | 2003

Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders

Matthew Frank Brown; Anderson See Gaweco; Ronald P. Gladue; Matthew Merrill Hayward


Archive | 2004

Tuteur modifie utile pour liberer des medicaments le long du support du tuteur

Paul S. Changelian; Anderson See Gaweco


Archive | 2003

Methods of using sulfonic acid derivatives

Matthew Frank Brown; Anderson See Gaweco; Ronald P. Gladue; Matthew Merrill Hayward

Researchain Logo
Decentralizing Knowledge